1. Trispecific Antibody against HIV-1 Demonstrate Anti-viral Activity in Vivo and Have Potent Fc-Dependent Effector Functions. Almasri, C., L. Xu, J. Dias, W. Promsote, R.N. Wei, D.M. Lord, E. Rao, J. Beninga, Z.Y. Yang, A. Pegu, J.R. Mascola, and G.J. Nabel. Journal of Immunology, 2020. 204(1 Supplement): 167.6. ISI[000589972402065].
[WOS]. HIV_01_2021.
2. Synthesis and Molecular Docking Studies of Quinoline Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors. Bhardwaj, N., D. Choudhary, A. Pathania, S. Baranwal, and P. Kumar. Turkish Journal of Chemistry, 2020. 44(6): p. 1623-1641. PMID[33488258]. PMCID[PMC7772092].
[PubMed]. HIV_01_2021.
3. Anti-HIV-1 Activity of pepRF1, a Proteolysis-resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein. Cadima-Couto, I., A. Tauzin, J.M. Freire, T.N. Figueira, R.D.M. Silva, C. Pérez-Peinado, C. Cunha-Santos, I. Bártolo, N. Taveira, L. Gano, J.D.G. Correia, J. Goncalves, F. Mammano, D. Andreu, M. Castanho, and A.S. Veiga. ACS Infectious Diseases, 2021. 7(1): p. 6-22. PMID[33319557].
[PubMed]. HIV_01_2021.
4. Design, Synthesis, and Antiviral Activity of a Series of CD4-mimetic Small-molecule HIV-1 Entry Inhibitors. Curreli, F., S. Ahmed, S.M. Benedict Victor, I.R. Iusupov, E.A. Spiridonov, D.S. Belov, A. Altieri, A.V. Kurkin, and A.K. Debnath. Bioorganic & Medicinal Chemistry, 2021. 32: 116000. PMID[33461144]. [PMC7856678].
[PubMed]. HIV_01_2021.
5. Novel Indolylarylsulfone Derivatives as Covalent HIV-1 Reverse Transcriptase Inhibitors Specifically Targeting the Drug-resistant Mutant Y181C. Gao, P., S. Song, E. Frutos-Beltrán, W. Li, B. Sun, D. Kang, J. Zou, J. Zhang, C. Pannecouque, E. De Clercq, L. Menéndez-Arias, P. Zhan, and X. Liu. Bioorganic & Medicinal Chemistry, 2021. 30: 115927. PMID[33352387].
[PubMed]. HIV_01_2021.
6. Structural Optimization of 2,3-Dihydro-1H-cyclopenta[b]quinolines Targeting the Noncatalytic RVxF Site of Protein Phosphatase 1 for HIV-1 Inhibition. Lin, X.H., A.M. Sajith, S.P. Wang, N. Kumari, M.S. Choy, A. Ahmad, D.R. Cadet, X.B. Gu, A.I. Ivanov, W. Peti, A. Kulkarni, and S. Nekhai. ACS Infectious Diseases, 2020. 6(12): p. 3190-3211. PMID[33258581]. PMCID[PMC7769123].
[PubMed]. HIV_01_2021.
7. Bioactive Daphnane Diterpenes from Wikstroemia chuii with Their Potential Anti-Inflammatory Effects and anti-HIV Activities. Liu, Y.Y., Y.P. Liu, X.P. Wang, Z.H. Qiao, X.M. Yu, Y.Z. Zhu, L. Xie, L. Qiang, and Y.H. Fu. Bioorganic Chemistry, 2020. 105: 104388. PMID[33130343].
[PubMed]. HIV_01_2021.
8. The Comparative Inhibitory Potency of Salivary Mucins against Human Immunodeficiency Virus Type 1. McQuaid, I.K., J.R. Dorfman, and A.S. Mall. Virology, 2021. 553: p. 1-8. PMID[33190061].
[PubMed]. HIV_01_2021.
9. Evaluation of pH-dependent Amphiphilic Carbosilane Dendrons in Micelle Formation, Drug Loading and HIV-1 Infection. Mencia, G., T. Lozano-Cruz, M. Valiente, J.L. Jimenez, F.J. de la Mata, M.A. Munoz-Fernandez, J. Cano, E. Gillies, and R. Gomez. Organic & Biomolecular Chemistry, 2020. 18(47): p. 9639-9652. PMID[33206746].
[PubMed]. HIV_01_2021.
10. Design and Synthesis of 4'-Cyano(dideoxy)isonucleosides and Their Activity against HIV-1 and HBV. Onitsuk, K., K. Yamaguchi, R. Tokuda, N. Higashi-Kuwata, S. Kuwahara, H. Kumamoto, K. Maeda, K. Haraguchi, H. Mitsuya, and S. Imoto. Heterocycles, 2020. 100(10): p. 1599-1612. ISI[000602679100003].
[WOS]. HIV_01_2021.
11. Study on Suitable Analysis Method for HIV-1 Non-catalytic Integrase Inhibitor. Park, K.H., M. Kim, S.E. Bae, H.J. Lee, K.C. Kim, B.S. Choi, and Y.B. Kim. Virology Journal, 2021. 18(1): 17. PMID[33436020]. PMCID[PMC7805210].
[PubMed]. HIV_01_2021.
12. Identification of an Antiretroviral Small Molecule That Appears to Be a Host-targeting Inhibitor of HIV-1 Assembly. Reed, J.C., D. Solas, A. Kitaygorodskyy, B. Freeman, D.T.B. Ressler, D.J. Phuong, J.V. Swain, K. Matlack, C.R. Hurt, V.R. Lingappa, and J.R. Lingappa. Journal of Virology, 2021. 95(3). PMID[33148797].
[PubMed]. HIV_01_2021.
13. Novel Peptides with HIV-1 Reverse Transcriptase Inhibitory Activity Derived from the Fruits of Quercus infectoria. Seetaha, S., S. Hannongbua, J. Rattanasrisomporn, and K. Choowongkomon. Chemical Biology & Drug Design, 2021. 97(1): p. 157-166. PMID[32757477].
[PubMed]. HIV_01_2021.
14. Structure-based Non-nucleoside Inhibitor Design: Developing Inhibitors That Are Effective against Resistant Mutants. Smith, S.J., G.T. Pauly, K. Hewlett, J.P. Schneider, and S.H. Hughes. Chemical Biology & Drug Design, 2021. 97(1): p. 4-17. PMID[32743937]. [PMC7821153].
[PubMed]. HIV_01_2021.
15. Potent Leads Based on CA-19L, an anti-HIV Active HIV-1 Capsid Fragment. Tsuji, K., R. Wang, T. Kobayakawa, K.B. Owusu, M. Fujino, M. Kaneko, N. Yamamoto, T. Murakami, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2021. 30: 115923. PMID[33316719].
[PubMed]. HIV_01_2021.
16. Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal. Turner, A.M.W., R. Dronamraju, F. Potjewyd, K.S. James, D.K. Winecoff, J.L. Kirchherr, N.M. Archin, E.P. Browne, B.D. Strahl, D.M. Margolis, and L.I. James. ACS Infectious Diseases, 2020. 6(7): p. 1719-1733. PMID[32347704]. PMCID[PMC7359025].
[PubMed]. HIV_01_2021.
17. An Efficient Microwave-mediated Synthesis of Hexavalent Sialic acid sulfoglycodendrimers as Potential anti-HIV Agents. Vierra, C., D.K. Eggers, C.C. LaBranche, and K.D. McReynolds. ACS Applied Polymer Materials, 2020. 2(11): p. 4345-4351. ISI[000592755800001].
[WOS]. HIV_01_2021.
18. Fullerene Derivatives as Dual Inhibitors of HIV-1 Reverse Transcriptase and Protease. Yasuno, T., T. Ohe, H. Kataoka, K. Hashimoto, Y. Ishikawa, K. Furukawa, Y. Tateishi, T. Kobayashi, K. Takahashi, S. Nakamura, and T. Mashino. Bioorganic & Medicinal Chemistry Letters, 2021. 31: 127675. PMID[33161121].
[PubMed]. HIV_01_2021.
19. Antiviral Potential of Natural Products from Marine Microbes. Yi, M.Q., S.X. Lin, B. Zhang, H.X. Jin, and L.J. Ding. European Journal of Medicinal Chemistry, 2020. 207: 112790. PMID [32937282]. PMCID[PMC7457942].
[PubMed]. HIV_01_2021.
Patent Citations
This month, no relevant HIV patents were identified.